Investors

We provide access to exclusive opportunities

Our experienced team of founders, board of directors and management team oversees has access to a diverse deal pipeline and has the requisite skills to evaluate this emerging investment opportunity.

$100 Billion Market Opportunity

Innovations in medicine are shifting the perspective of mental illness and addiction.

Despite commercial success of conventional medications to treat mental illness and addiction, many leading experts have been disappointed in their efficacy. 

1 in 5 Canadians experience a mental illness or addiction problem every year, and by the age of 49, 1 in 2 have—or have had—a mental illness.

Mental illness is the leading cause of disability in Canada, and are more likely to cause people to die prematurely than the general population, cutting 10-20 years from a person’s life expectancy.

Investment Highlights

Origin provides early access

to privately-held, rapidly growing companies in the psychedelic space.

Many companies have emerged

to take advantage of this opportunity and are raising early seed capital from sophisticated venture capitalists.

Diversified portfolio

of companies to maximize exposure to the psychedelic industry while managing risk.

Powerhouse team

The members of Origin’s Board and management team have been involved in some of the fastest growing companies in their respective industries.

Origin knows how to grow companies

Origin actively manages its investments through board representation and/or advisory roles.

emerging industry with high growth trajectory

Increasingly competitive landscape

Hundreds of companies have emerged to take advantage of this $100 billion market opportunity.

Retail investors often have little access

The most promising companies in the psychedelic space are often privately held and raise capital from sophisticated investors.

Early investors reap significant rewards

Early investors in those companies reap significant rewards when they eventually go public.

The founding shareholders and board of directors of Origin are founders and/or early investors in these companies

Capitalization

SHARES OUTSTANDING
FOUNDERS / BOARD OF DIRECTORS / MANAGEMENT
34,000,000
$5M+ FINANCING @ $0.25¹
20,000,000+
TOTAL
54,000,000
OPTIONS
5,400,000
TOTAL DILUTED
59,400,000

1 Financing is structured as a $0.25 special warrant. The Company intends to use the proceeds of the financing for investments, general working capital, and listing on a publicly-traded stock exchange.

Talk to Our Team

Want to make psychedelic therapy part of your investing strategy? Connect with our team to find out more.